Gene Signal SAS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG (NCT02947867) | Gene Signal SAS | 2017-01-01 |
Track Gene Signal SAS automatically
Every clearance here is in the API, with alerts when new ones post.